AAAAAA

   
Results: 1-9 |
Results: 9
A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenousleukemia in first chronic phase
Authors: Elmaagacli, AH Runkel, K Steckel, N Opalka, B Trenschel, R Seeber, S Schaefer, UW Beelen, DW
Citation: Ah. Elmaagacli et al., A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenousleukemia in first chronic phase, BONE MAR TR, 27(8), 2001, pp. 809-815
Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR-ABL fusion transcripts detected using a new real-time polymerase chain reaction method
Authors: Elmaagacli, AH Freist, A Hahn, M Opalka, B Seeber, S Schaefer, UW Beelen, DW
Citation: Ah. Elmaagacli et al., Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR-ABL fusion transcripts detected using a new real-time polymerase chain reaction method, BR J HAEM, 113(4), 2001, pp. 1072-1075
The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage
Authors: Elmaagacli, AH Beelen, DW Opalka, B Seeber, S Schafer, UW
Citation: Ah. Elmaagacli et al., The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage, ANN HEMATOL, 79(8), 2000, pp. 424-431
Quality assurance in RT-PCR-based BCR/ABL diagnostics - results of an interlaboratory test and a standardization approach
Authors: Burmeister, T Maurer, J Aivado, M Elmaagacli, AH Grunebach, F Held, KR Hess, G Hochhaus, A Hoppner, W Lentes, KU Lubbert, M Schafer, KL Schafhausen, P Schmidt, CA Schuler, F Seeger, K Seelig, R Thiede, C Viehmann, S Weber, C Wilhelm, S Christmann, A Clement, JH Ebener, U Enczmann, J Leo, R Schleuning, M Schoch, R Thiel, E
Citation: T. Burmeister et al., Quality assurance in RT-PCR-based BCR/ABL diagnostics - results of an interlaboratory test and a standardization approach, LEUKEMIA, 14(10), 2000, pp. 1850-1856
Human herpesvirus 6 is an important pathogen in infectious lung disease after allogeneic bone marrow transplantation
Authors: Buchbinder, S Elmaagacli, AH Schaefer, UW Roggendorf, M
Citation: S. Buchbinder et al., Human herpesvirus 6 is an important pathogen in infectious lung disease after allogeneic bone marrow transplantation, BONE MAR TR, 26(6), 2000, pp. 639-644
The detection of wt-1 transcripts is not associated with an increased leukemic relapse rate in patients with acute leukemia after allogeneic bone marrow or peripheral blood stem cell transplantation
Authors: Elmaagacli, AH Beelen, DW Trenschel, R Schaefer, UW
Citation: Ah. Elmaagacli et al., The detection of wt-1 transcripts is not associated with an increased leukemic relapse rate in patients with acute leukemia after allogeneic bone marrow or peripheral blood stem cell transplantation, BONE MAR TR, 25(1), 2000, pp. 91-96
Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation
Authors: Elmaagacli, AH Beelen, DW Trenn, G Schmidt, O Nahler, M Schaefer, UW
Citation: Ah. Elmaagacli et al., Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation, BONE MAR TR, 23(8), 1999, pp. 771-777
The risk of residual molecular and cytogenetic disease in patients with Philadelphia-chromosome positive first chronic phase chronic myelogenous leukemia is reduced after transplantation of allogeneic peripheral blood stem cells compared with bone marrow
Authors: Elmaagacli, AH Beelen, DW Opalka, B Seeber, S Schaefer, UW
Citation: Ah. Elmaagacli et al., The risk of residual molecular and cytogenetic disease in patients with Philadelphia-chromosome positive first chronic phase chronic myelogenous leukemia is reduced after transplantation of allogeneic peripheral blood stem cells compared with bone marrow, BLOOD, 94(2), 1999, pp. 384-389
The adverse influence of pretransplant interferon-alpha (IFN-alpha) on transplant outcome after marrow transplantation for chronic phase chronic myelogenous leukemia increases with the duration of IFN-alpha exposure
Authors: Beelen, DW Elmaagacli, AH Schaefer, UW
Citation: Dw. Beelen et al., The adverse influence of pretransplant interferon-alpha (IFN-alpha) on transplant outcome after marrow transplantation for chronic phase chronic myelogenous leukemia increases with the duration of IFN-alpha exposure, BLOOD, 93(5), 1999, pp. 1779-1780
Risultati: 1-9 |